Ms. Holly (Ruma) Magliochetti is a seasoned executive with over 25 years of management experience. Her experience in evaluating investments combined with 15+ years in the banking and investment banking industries brings a strong analytical and transaction-focused skill set to developing and implementing growth focused corporate strategies.
Ms. Magliochetti, prior to founding Genetics Institute of America Laboratory, founded Grace Health Technology Corp. Grace Health Technology offers an enterprise solution (Chain Link) for the Laboratory environment. Chain Link focuses on the interaction and interchange between the internal and external sales channel with the operations of the laboratory. Chain Link captures customer acquisition, customer demographics including insurance status, shipping and receiving information, inventory management as well as completed physician signed requisition orders. All of the captured and input data is maintained in a HIPAA compliant ecosystem.
Prior to forming Grace, Ms. Magliochetti served as the President of Sympta Corp a patient allergy Company focused on providing in physician office allergy testing. Holly was President and CEO of IPC Sports Corp. At IPC Sports Corp., Ms. Magliochetti oversaw the company’s rapid expansion and successful development of multiple new product lines, including the NBA and MLB licensed Fan Band. Prior to joining IPC, Ms. Magliochetti was Managing Partner for real estate development and technology at Archer Capital. She has also held management positions with GMAC, MFS, Travelers Group and BayBank. Ms. Magliochetti has served on the New England Regional Advisory Board for Buffini & Co. as well as the Board of Directors for Healthworks. She attended Newbury College, the University of Massachusetts and currently holds an active FL real estate license. She is a devout Christian, an active outdoor enthusiast, and has competed in the Boston Marathon.
Now Offering the GIAnomics™ Family of Genomics Tests
We offer extensive clinical products and services to patients, medical professionals, and businesses. Who do you know that needs to know?